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Background:  Research identifies highly variable prevalence estimates for Autism Spectrum 
Disorder (ASD) in children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD), 
particularly between community and clinical samples, warranting quantitative meta-analyses to 
investigate the true prevalence of ASD in children and adolescents with ADHD.  
Methods: Studies were identified through a systematic literature search of PsycINFO, MEDLINE 
and Web of Science through January 2018.  Twenty-two publications met inclusion criteria (Total 
N=61,985).  Two random effects meta-analyses were conducted: (1) to identify the proportion of 
children and adolescents with ADHD that met criteria for ASD; and (2) to compare the severity of 
dimensionally-measured ASD symptomology in children and adolescents with and without 
ADHD.  
Results: The overall pooled effect for children and adolescents with ADHD who met threshold for 
ASD was 21%.  There was no significant difference between community samples (19%) and 
clinical samples (24%) or between US studies versus those from other countries.  Children and 
adolescents with ADHD had substantially more dimensionally-measured ASD traits compared 
with those who did not have ADHD (d=1.23).   
Conclusion:  The findings provide further evidence that ADHD and ASD are associated in nature.  








Attention Deficit Hyperactivity Disorder (ADHD) 
ADHD is a neurodevelopmental disorder, characterised by attentional and/or 
hyperactive/impulsive traits (American Psychiatric Association (APA), 2013).  The worldwide-
pooled prevalence rate of ADHD in children is 5-7% (Polanczyk, Lima, Horta, Biederman & Rohde, 
2007; Thomas, Sanders, Doust, Beller & Glasziou, 2015) making it one of the most common 
childhood disorders.  Despite variability between countries, including higher rates identified 
within the US, the prevalence of ADHD is relatively comparable across US and non-US countries 
(Faraone, Sergeant, Gillberg & Biederman, 2003).   
 
Childhood ADHD is associated with impaired function across a range of domains (Shaw et al., 
2012) including poorer academic and educational outcomes (Loe & Feldman, 2007), and 
difficulties establishing and maintaining peer relationships (Hoza, 2007).  Symptoms of ADHD are 
associated with impaired social problem-solving (Matthys, Cuperus, & van Engeland, 1999), social 
immaturity and peer rejection (Carpenter Rich, Loo, Yang, Dang & Smalley, 2009), social cognitive 
impairments, including emotional face and prosody perception (Uekermann, et al., 2010), 
emotional dysregulation, including more aggressive and negative behaviour (Wheeler-Maedgen 
& Carlson, 2000; DuPaul, McGoey, Eckert & VanBrakle, 2001), poorer social and communicational 
skills (Klimkeit et al., 2006), language impairment, specifically communication and language 
comprehension (Bruce, Thernlund & Nettelbladt, 2006), and deficits in working memory and 
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executive functioning (Kofler et al., 2011).  Although the majority of studies have examined the 
functional impairments experienced by males with ADHD, deficits in interpersonal functioning 
are also present in females with the condition (Greene, et al., 2001). 
 
High rates of co-occurring conditions have been identified for children and adolescents diagnosed 
with ADHD including mood, anxiety and conduct disorders (Cantwell, 1996; Spencer, 2006).  
Disruptive behaviour (which includes substance abuse), neurological, learning and cognitive 
difficulties, obsessive-compulsive and tic disorders have also been found to co-occur with ADHD 
at rates substantially above chance (Pliszka, Carlson, & Swanson, 1999; Kessler et al., 2006).  
Furthermore, high rates of neurodevelopmental conditions such as intellectual disability, tic 
disorder and social communication disorders, such as autistic spectrum disorder (ASD), are 
frequently found to co-occur with ADHD (Larson, Russ, Kahn, & Halfon, 2011; Cantwell, 1996; 
Jensen & Steinhausen, 2015; Young et al., 2018).   
 
Autistic Spectrum Disorders (ASD) 
The estimated prevalence of ASD, worldwide, is between 0.6 and 1% (Elsabbagh et al., 2012; 
Baird et al., 2006).  ASD is a highly heritable neurodevelopmental condition characterised by 
persistent deficits in social communication and social interaction and restricted, repetitive 
patterns of behaviour, interests or activities (APA, 2013).  Previous diagnostic systems (Diagnostic 
and Statistical Manual of Mental Disorders 4th Edition and International Classification of Diseases 
10th Revision) distinguished between different subtypes of ASD, namely autistic disorder, 
Asperger’s disorder, pervasive developmental disorder – not otherwise specified (PDD-NOS). 
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However, it was not possible to reliably distinguish between them (Lord et al., 2012; Berument, 
Rutter, Lord, Pickles & Bailey, 1999; Hattori et al., 2006). These conditions share common genetic 
aetiologies (Frazier et al., 2012; Mahjouri & Lord, 2012) and symptoms of ASD can change over 
time, leading to potential movement between diagnostic categories (Lord et al., 2006). As a 
result, DSM-5 subsumed all autistic subtypes under one overall diagnostic category of ASD (APA, 
2013). Further, ASD is increasingly understood as a dimensional condition, representing the 
extreme of a trait dimension of autistic symptoms that extends throughout the general 
population, with no natural boundary between autism and non-autism (Constantino & Todd, 
2003).  Similar considerations have been raised for ADHD subtypes (Willcutt et al., 2012). 
 
ADHD and ASD  
Following social anxiety disorder, ADHD is the second most common co-occurring mental 
disorder in individuals diagnosed with ASD (Simonoff et al., 2008).  There is significant variability 
between identified rates, ranging from 28.2% to 31% in community samples (Simonoff et al., 
2008; Leyfer et al., 2006) and higher rates of 53% and 78% in clinical samples (Sinzig, Walter, 
Doepfner, 2009; Lee & Ousley, 2006). 
 
Conversely, elevated levels of ASD symptoms have been identified in children and adolescents 
with ADHD.  Studies examining the proportion of children with ADHD that also met criteria for 
ASD, have found rates between 4.68% - 32% (Riersen et al., 2007; Grzadzinski et al., 2011; 
Grzadzinski, Dick, Lord, & Bishop, 2016; Kochhar et al., 2011; Kotte et al., 2013; Ronald, Simonoff, 
Kuntsi, Asherson, & Plomin, 2008; Russell, Rodgers, Ukoumunne, & Ford, 2014) across clinical 
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and community samples, leading to considerable uncertainty as to the true rates.  Variability in 
the frequency of reported ASD in child and adolescent ADHD populations is likely to be due to 
methodological differences including sampling, measures and thresholds (Reiersen, Constantino, 
Volk & Todd, 2007; Grzadzinski et al., 2011).  This can impede the accurate assessment and 
identification of prevalence rates (Boyle, 1998; Hoy et al., 2012).  Gender differences have been 
identified, with evidence suggesting that boys with ADHD experience more ASD symptoms than 
girls (Green et al., 2015; Mulligan et al., 2009).  However, it is important to recognise that such 
findings may partly reflect difficulties with identifying ASD in girls (Lai, Lombardo, Auyeung, 
Chakrabarti & Baron-Cohen, 2015; Mandy et al., 2012).   
 
Despite variation, the higher rates of co-occurrence identified in young people with ASD and 
ADHD dwarf rates identified in the general population for either condition independently, thus 
precluding that these co-occurrence rates happen by chance.  A number of models of comorbidity 
have been proposed to explain these high rates of co-occurrence.  For example, whether the 
presence of one condition increases the risk of the other (multiformity), that specific risk factors 
for both conditions are correlated, or that the two conditions share genetic risk factors but are 
different phenotypic expressions (pleiotropy).  These models go some way in helping us 






Children with ADHD share a number of difficulties with children with ASD, including social 
impairments (Santosh & Mijovic, 2004), language difficulties (Bishop & Baird, 2001), behavioural 
difficulties (Clark, Feehan, Tinline, & Vostanis, 1999; Gadow, DeVincent, Pomeroy & Azizian, 
2005), attentional and overactivity problems (APA, 2013; Rao and Landa, 2014).  Shared 
difficulties with communicative and stereotyped and repetitive behaviours have also been 
identified (Clark et al., 1999; Santosh & Mijovic, 2004).  Distinguishing between similar 
presentations often relies on clinical judgement and an in depth understanding of both 
conditions.  For example, a child who is hyperactive may be talkative to the extent that it is 
inappropriate.  They may be aware that this is inappropriate but find it difficult to stop 
themselves.  A child with ASD speaking in a monologue may also present as overly talkative, but 
is less likely to have the social awareness to realise that this is inappropriate.  Therefore, the same 
observable behaviour may be the result of symptoms of ADHD, ASD or a combination of both.   
 
There are behavioural parallels and diagnostic similarities between ADHD and ASD.  (Gadow, et 
al., 2005; Holtmann, Bölte, & Poustka, 2007; Simonoff et al., 2008). This can lead to difficulties 
distinguishing the conditions from one another (Buitelaar, van der Wees, Swaab‐Barneveld, & 
van der Gaag, 1999; Grzadzinski, Dick, Lord, & Bishop, 2016) and  misdiagnosis (Sikora, Hartley, 
McCoy, Gerrard-Morris & Dill, 2008), which impacts upon clinical care.  The domain of restricted, 
repetitive and stereotyped patterns of behaviour, rather than social communication difficulties, 




Prior to the publication of the DSM-5 (APA, 2013), comorbidity between the two disorders was 
not permitted, despite recognition that symptoms overlap.  The DSM-IV (APA, 2000) identified 
that children often receive a diagnosis of ADHD prior to a diagnosis of ASD.  It also prohibited the 
diagnosis of ADHD if symptoms of inattention and hyperactivity occurred during the course of a 
pervasive developmental disorder.  Therefore, despite the overlapping symptomology, 
diagnostic similarities and whether an individual met the diagnostic criteria for both ADHD and 
ASD, a dual diagnosis could not be given.  The DSM-5 takes more recent research into account 
and allows for a dual diagnosis of ADHD and ASD.   
 
Current Study 
Now that a dual diagnosis of ADHD and ASD is accepted, there is a need to develop understanding 
as to prevalence rates and clinical implications of co-morbid ADHD and ASD.  To date only a few 
studies have attempted to identify the prevalence rate of ASD in children and adolescents with 
ADHD.  These studies have utilised varying methodologies and assessments of ASD, resulting in 
discrepancies between the findings.  Therefore, combining the findings from these studies may 
provide a more accurate reflection of the true proportion of children and adolescents with ADHD 
who also experience ASD symptoms, irrespective of diagnostic category.  More specifically, it will 
identify the frequency of ASD symptoms found in children and adolescents with ADHD.   
 
Research Questions: 
 What proportion of children and adolescents with ADHD meet diagnostic criteria for ASD?  
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 What is the mean difference of dimensionally-measured ASD symptoms in children with 





The ‘Preferred Reporting Items for Systematic Reviews and Meta-Analyses’ (PRISMA) guidelines 
were followed (Moher, Liberati, Tetzlaff & Altman, 2009; Liberati et al., 2009).  The literature 
search was conducted in January 2018.  Terms for ADHD (“attention deficit hyperactivity 
disorder” OR ADHD OR ADD OR “hyperkinetic disorder”) and ASD (ASD OR “Autism” OR 
“Asperger’s” OR PDD OR PDD-NOS) were searched independently within the titles and abstracts 
of articles within the following databases; PsycINFO, MEDLINE and Web of Science.  These 
independent searches were then combined to identify articles who reported both terms for 
ADHD and terms for ASD within their titles and abstracts.   
 
Identified abstracts were reviewed for their suitability in accordance with the eligibility criteria 
described below.  The reference lists of included studies were searched to identify papers that 
met inclusion criteria, but were not identified in the electronic database search.  
 
Study Selection 
In the first instance, duplicate articles were removed and the inclusion and exclusion screening 
process was conducted.  The screening process, risk of bias and data extraction were completed 
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independently by two researchers (JH and AF), who compared their results and sought a 
consensus when there was disagreement.  Any dilemmas that could not be resolved between the 
two raters were raised with the supervising author (WM).  Based on risk of bias criteria by Hoy 
and colleagues (2012), only one study was identified to have no risk of bias (Jensen et al., 2015).  
All other studies were identified to hold the same risk of bias.  Due to a lack of variability of risk 
of bias between studies no bias comparison analysis was warranted.  Studies were included if 
they were peer reviewed articles written in English, had samples aged between 2-19 years, used 
either clinical or community populations, and reported the appropriate statistical data for meta-
analyses, specifically means, standard deviations and percentages.  Studies were not excluded 
based on their country of origin, sample size or publication date.   
 
In some instances, studies utilised the same population sample, therefore, in order to reduce bias 
the study with the highest N was included (Green et al., 2015; Reiersen, et al., 2007; Tye et al., 
2014) and the smaller study removed (Reiersen, Constantino & Todd, 2008; Green et al., 2016, 
Green et al., 2017; Tye et al., 2016). One study did not use a validated measure of ASD (Santosh 
& Mijovic, 2004) and therefore was excluded from the analysis.  Five studies failed to report the 
required statistical data and were contacted directly (Clark et al., 1999; Clark et al., 2011; Hattori 
et al., 2006; Mohiuddin et al., 2010; Mulligan, Butler, Sorohan, Fitzgerald & Gill, 2005).  The 
requests yielded no response and therefore these papers were omitted from further analysis.  In 
two cases, having a pre-existing diagnosis of ASD was an exclusion criterion and therefore these 




For studies where the data was split by ADHD presentation or gender, pooled means and 
standard deviations were calculated (Reiersen et al., 2007; Ayaz, Gökçe, Gümüştaş, & Ayaz, 2014; 
Mayes, Calhoun, Mayes, & Molitoris, 2012).  In studies that utilised multiple measures to identify 
social communication difficulties (Ayaz et al., 2014; Luteijnet al., 2000; Kochhar et al., 2010; van 




Meta-analyses were conducted using STATA Version 14 (Statacorp, 2015).  For both analyses, 
homogeneity was not assumed due to the methodological variability between studies and 
therefore a random-effect model was fitted to the data to allow for variation in the true effect 
size (Brockwell & Gordon, 2001).  Heterogeneity was assessed using the χ 2 and I2 statistics.   
 
To address the first research question (what proportion of children and adolescents with ADHD 
also meet diagnostic criteria for ASD?), a proportional meta-analysis using the STATA ‘metaprop’ 
command was conducted on studies that reported estimated prevalence rates of ASD within 
children and adolescents diagnosed with ADHD.  Along with ASD diagnostic tools, including the 
Autism Diagnostic Observation Schedule - Version 2 (ADOS-2) (Lord, Luyster, Gotham, & Guthrie, 
2012; Lord et al., 2012), Autism Diagnostic Interview-Revised (ADI-R) (Rutter, Le Couteur, Lord, 
2003), International Classification of Diseases – 10 (ICD-10) (World Health Organization, 1994), 
the Development and Well-being assessment (DAWBA) (Goodman, Ford, Richards, Gatward, & 
Meltzer, 2000), and parents who had been informed by a mental health professional that their 
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child had ASD, ASD screening tools (ASD-Tics, ADHD and other Comorbidities Inventory (A-TAC) 
(Hasson et al., 2005), Social Communication Questionnaire (SCQ) (Rutter, Bailey & Lord, 2003), 
Social Responsiveness Scale (SRS) (Constantino & Gruber, 2012) and Child Behaviour Checklist’s 
(CBCL) (Withdrawal, Social Problems and Thought problems T-scores) (Achenbach & Edelbrock, 
1991) were also included due to their clinical validity, specifically their sensitivity and specificity 
of identifying ASD (Bölte, Westerwald, Holtmann, Freitag, & Poustka, 2011; Charman et al., 2007; 
Hansson et al., 2005; Larson et al., 2010; Biederman et al., 2010).  Individuals meeting clinical 
threshold for ASD on screening tools were considered appropriate to include within the study.   
 
A second meta-analysis was conducted using the STATA ‘metan’ command to address the second 
research question (what is the mean difference of dimensionally-measured ASD symptoms in 
children with ADHD and children without ADHD?).  A pooled standardised mean difference was 
calculated.   
 
For both meta-analyses, further exploratory subgroup meta-analysis was conducted when 
significant heterogeneity was identified between studies.  Subgroups were defined according to 
variables identified by the study team as plausible influences of estimated prevalence rates.  
Firstly, due to there being higher rates of comorbidity in clinically referred populations, we 
compared papers drawing on clinical and community samples (Low, Cui, & Merikangas, 2008).  
Secondly, the type of measure used to identify ASD caseness can affect the number of symptoms 
identified and diagnostic outcome (Boyle, 1998; Hoy et al., 2012) so papers were compared 
depending on whether they had used a screening questionnaire or a more comprehensive 
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diagnostic test.  Thirdly, due to the variability in prevalence rates between US and non-US 
countries (Faraone et al., 2003) samples were divided by country (US vs Non-US).   
 
Results 
A flow diagram of the search strategy is presented in Figure 1.  A total of 22 studies met inclusion 
criteria for the two meta-analyses and were included in study.  After the screening and evaluation 
of papers, 13 studies were included within the final proportion meta-analysis, with a total sample 
size of 57,058 participants from six countries.  A description of the studies is provided in Table 1.  
After further evaluation, 15 studies were also included within the mean difference meta-analysis, 

































































The results of the meta-analyses are summarised in Table 3.  The overall pooled effect size was 
0.21 [0.18-0.24], indicating that 21% of children and adolescents with ADHD also meet respective 
thresholds for ASD. The Forest Plot is presented in Figure 2.   
 
The I2 statistic was 87.25%, p<.01 indicating that there was a high amount of heterogeneity 
between the studies (Higgins, Thompson, Deeks, & Altman, 2003), therefore further analysis was 
conducted in order to investigate influences on variability of the pool prevalence estimate. 
 
Clinical versus Community ADHD samples 
Studies that used a clinical sample (Craig et al., 2015, Grzadzinski et al., 2016, Grzadzinski et al., 
2011, Kochhar et al., 2010, Kotte et al., 2013, Salley et al., 2015) tended to find a higher 
prevalence of ASD (see Table 3) compared to those that used a community sample (Green et al., 
2015, Jensen et al., 2015, Lichtenstein et al., 2010, Reiersen et al., 2007, Ronald et al., 2008, 
Russell et al., 2014, Zablotsky et al., 2017) (0.19 ; 95% CI, 0.16-0.22).  However, as is shown in 
Table 3, there was no evidence that this difference is significant as the confidence intervals for 
these pooled estimates overlapped.  There was a significantly high level of heterogeneity among 
the studies that used both clinical samples and community samples.   
 
Screening Tools versus Diagnostic Tools 
Studies were divided into those that used screening tools (Craig et al., 2015, Green et al., 2015, 
Grzadzinski et al., 2011, Kochhar et al., 2010, Kotte et al., 2013, Lichtenstein et al., 2010, Reiersen 
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et al., 2007, Ronald et al., 2008, Zablotsky et al., 2017) and those that used more comprehensive 
diagnostic tests (Grzadzinski et al., 2016, Jensen et al., 2015, Russell et al., 2014, Salley et al., 
2015).  As is shown in Table 3, studies that used screening tools as their primary outcome 
measure of ASD symptoms identified a similar random pooled effect size compared to studies 
that used diagnostic instruments to evaluate the presence of ASD symptoms.  There were also 
similar rates of heterogeneity between those studies that used screening tools (80.10%) and 
those that used diagnostic tools (86.52%).   
 
US versus Non-US Studies  
Variations in ADHD prevalence rates have been identified between US and non-US studies 
(Faraone et al., 2003).  As shown in Table 3, US studies (Grzadzinski et al., 2011, Grzadzinski et 
al., 2016, Kotte et al., 2013, Reiersen et al., 2007, Salley et al., 2015, Zablotsky et al., 2017) were 
identified to have a similar random pooled effect size to non-US studies (Craig et al., 2015, Green 
et al., 2015, Jensen et al., 2015, Kochhar et al., 2010, Lichtenstein et al., 2010, Ronald et al., 2008, 
Russell et al., 2014).  High levels of heterogeneity were identified in both US studies (78.61%) and 





















Mean Difference Meta-analysis 
The overall pooled standardised mean difference of ASD symptoms between children and 
adolescents with ADHD and those without ADHD was 1.23, 95% CI [0.94– 1.51], illustrated in 
the Forest Plot in Figure 3.  There was a high level of heterogeneity between the studies (I2 = 
93.4%),therefore further subgroup analyses were conducted as a preliminary exploration of 
this variability (Wykes, Huddy, Cellard, McGurk, & Czobor, 2011).  A more detailed 
investigation into the identified variability was restricted due to the small number of studies 





















Clinical versus Community ADHD samples 
Due to known differences, clinical and community samples studies were separated by sample 
type (Low, Cui, & Merikangas, 2008).  As seen in Table 3, studies that used a clinical sample 
(Ayaz et al., 2014; Craig et al., 2015, Kochhar et al., 2010, Kotte et al., 2013, Kopp et al., 2011, 
Lutejin et al., 2000; Mayes et al., 2012; Mulligan et al., 2009, Nijmeijer et al., 2009, Salley et 
al., 2015, Tye et al., 2014) were identified to have a higher pooled mean difference than 
studies that used a community sample (Green et al., 2015, Grzadzinski et al., 2011, Reiersen 
et al., 2007, van der Meer et al., 2012, van Steijn et al., 2014).  Confidence intervals indicate 
that the pooled mean difference between the two groups was not significant.  There was a 
significantly high level of heterogeneity between both clinical and community samples.  





















To the authors knowledge these are the first meta-analyses to consolidate the literature on 
rates of ASD and ASD symptoms in children and adolescents with ADHD.  High levels of 
heterogeneity were identified between both the proportional studies and mean difference 
studies, therefore further subgroup analysis was conducted to better understand this 
variability.  Although it has been identified that five or more studies are sufficient to achieve 
adequate power to detect effects within random effects meta-analyses (Jackson & Turner, 
2017), the current meta-analyses, with small numbers of studies is subject to low power. 
 
The proportional meta-analysis identified that 21% of the children and adolescents with 
ADHD also met criteria for ASD.  This is comparable with Ronald and colleagues’ (2008) 
findings using a robust diagnostic measure, and only slightly higher than the 15% identified 
by Grzadzinski and colleagues (2016) who utilised the “gold standard” diagnostic tools.  Thus, 
both ASD and traits of ASD can be considered as a common occurrence in children and 
adolescents with ADHD.   
 
To put this in context, a number of co-occurring conditions have been identified to coexist 
with ADHD (Patel, Patel & Patel, 2012).  For example, intellectual disability has been identified 
to co-occur in up to 46% of young people with ADHD (Larson et al., 2011). Depression and 
depressive symptomology have been found within 10-40% (Spencer, Biederman & Wilens, 
1999) of children and adolescents with ADHD.  Prevalence rates of ADHD and comorbid 
anxiety disorders have been identified, ranging between 5-50% (Pliszka et al., 1999; Mancini, 
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Van Ameringen, Oakman, & Figueiredo, 1999) with a large proportion having multiple anxiety 
disorders (Spencer, Biederman & Wilens; 1999).  Conduct Disorder and Oppositional Defiant 
Disorder are two of the most commonly identified comorbid disorders, with rates ranging 
between 15% and 59% respectively in school-aged children (Wilens et al., 2002).  Therefore, 
ASD symptoms form part of the wider complexity of the multimorbid conditions associated 
with ADHD. 
 
Due to the high levels of heterogeneity, studies were divided by their sample type (clinical vs. 
community), ASD measurement type (screening vs diagnostic) and country of origin (USA vs. 
non-US) as can be seen in Table 1.  Moderate to high heterogeneity was identified within all 
subgroups.  Due to the small number of studies included within the meta-analysis and 
subsequent subgroup analyses, there are limited conclusions that can be drawn to accurately 
explain the variability between studies.  Nevertheless, it is interesting to note that studies 
using screening instruments identified a similar ASD prevalence (22%) as those using more 
comprehensive diagnostic assessments (20%). One interpretation of this is that screening 
measures are useful tools for identifying ASD in ADHD populations. However, it should be 
acknowledged that individuals identified as having ASD via screening questionnaires may not 
fully overlap with those identified as having ASD via diagnostic assessment. This should be 
empirically tested to understand more about the accuracy of ASD screening measures when 
used in those with a primary diagnosis of ADHD.  
 
The results from the second meta-analysis identified an overall pooled standardised mean 
difference of ASD symptoms, between children and adolescents with ADHD and those 
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without, of 1.23, representing a large effect.  There was a high level of heterogeneity between 
the studies and therefore further subgroup analysis (clinical vs. non-clinical) was conducted 
as a preliminary attempt to explore this variability.  High heterogeneity was identified 
between the studies in both sub-groups.  Despite different methodologies and variability 
between studies, higher rates of ASD symptomology were identified within the ADHD groups 
compared with their non-ADHD groups in all cases.   
 
Two possible explanations could be proposed to explain the current findings.  Firstly, it is likely 
that measures used to identify ASD symptomology found characteristics of ADHD that 
diagnostically overlap, such as social impairment (Santosh & Mijovic, 2004).  These overlaps 
may have impacted on the rates of comorbidity identified.  However, ASD diagnostic tools 
such as the ADI-R, ADOS-2 and DAWBA would have identified the presence of restrictive, 
repetitive and stereotyped patterns of behaviour which are not understood to be diagnostic 
features of ADHD (Hartley & Sikora, 2009). Screening measures such as the SCQ and SRS 
identified comparable rates of ASD within children and adolescents with ADHD, indicating 
these were also effective in distinguishing between the two disorders (Kochhar et al., 2011; 
Kotte et al., 2013).  Thus, it is unlikely that the comorbidity rates were substantially inflated 
as a result of overlapping symptoms.   
 
The second possible explanation is that other shared causal processes between the two 
conditions can account for the high rates of overlapping symptoms (Mayes et al., 2012) and 
behaviours (Ronald et al., 2008).  As well as the shared diagnostic overlap (APA, 2000; APA, 
2013), research has identified shared genetic origins for ADHD and ASD conditions (Taurines 
26 
 
et al., 2012; Reiersen, Constantino, Grimmer, Martin & Todd, 2008; Ronald, Simonoff, Kuntsi, 
Asherson, & Plomin, 2008; Rommelse, Franke, Geurts, Hartmann & Buitelaar, 2010), leading 
some to consider that they may in fact be two aspects of the same disorder (Lee et al., 2013, 
van de Meer et al., 2012).  However, genetics alone cannot account for the rates of co-
occurrence.  Genome-wide association studies have only identified a moderate association 
between ADHD and ASD (rG = 0.360) (Grove et al., 2017) and underlying genetic risk factors 
may differ between the two conditions (van Steijn et al., 2012).  Therefore, it may be that the 
same genes, or combination of genes, in conjunction with environmental interactions are 
responsible for creating distinct ADHD and ASD phenotypes (Kiser, Rivero & Lesch, 2015).   
 
ADHD and ASD can be dissociated across a range of cognitive domains on the basis of their 
neural responses.  For example, differences in response time variability under slow and fast 
incentive conditions (Tye et al., 2015), neurophysiological responses to faces and gaze 
direction (Tye et al., 2013) and emotional faces (Tye et al., 2014), and in attentional 
orientating and inhibitory control (Tye et al., 2014).  Overall, the work from Tye and colleagues 
identifies distinct cognitive functioning between the two conditions.  However, children with 
both ASD+ADHD have the unique profiles of the 'pure' disorders, acting like an additive 
condition.   
 
Overall, the findings from this study support our understanding of the extent to which these 
two conditions are associated in nature.  Based on the current study it is not possible to 
determine causal mechanisms, however assumptions can be made in regard to shared genetic 




It is also important to note that only two of the included studies utilised DSM-5 criteria 
(Grzadzinski et al., 2016 and Salley et al., 2015) for ADHD and ASD.  There was no obvious 
pattern from this very small sample of DSM-5 studies; the identified prevalence rates from 
these studies represent one of the lowest (15%) and highest (40%) rates found.  In light of the 
changes within the DSM-5, and upcoming International Classification of Diseases - 11th 
revision, which have lowered the symptom threshold for ADHD but increased the 
requirements for a diagnosis of ASD, specifically the presence of restricted, repetitive and 
stereotyped behaviours (APA, 2013), it is not clear how the co-occurring prevalence rates of 
these conditions will be affected.  It is possible that the prevalence of ADHD within child and 
adolescent populations will increase and consequently increase the number of children who 
may be identified to have co-occurring ASD symptomology.  Alternatively, the requirement 
that restricted, repetitive and stereotyped behaviours be present for a diagnosis of ASD, 
which are not characteristics of ADHD, may reduce diagnostic comorbidity.  The latter 
explanation may account for the relatively lower prevalence rates identified within 
Grzadzinski and colleagues 2016 study. 
 
Limitations and Recommendations 
A limitation of the current study is the relatively small number of papers (N=22, total 
sample=61,985 from both proportional and mean difference analyses) that were available to 
include within the meta-analysis.  Methodologies between studies varied considerably and 
this may have affected the overall findings (Lipsey & Wilson, 2001).  The limited number of 
available studies also had an impact on the ability of the authors to explore the observed 
heterogeneity between studies.  More studies that utilise more robust methodologies are 




The current study found that there was no significant difference between screeners and more 
robust diagnostic assessments when assessing for ASD symptomology in young people with 
ADHD.  This suggests that overall the screeners used in this study demonstrate clinical utility 
comparable to that of the diagnostic measures used.  However, it should be noted that the 
current ASD measures were developed under the previous categorical diagnostic 
understanding of ASD and may not be the most effective tools for measuring a continuum of 
symptoms, in accordance with our current understandings of ASD.  For example, the SCQ was 
developed to distinguish between different ASDs and therefore may not be as effective at 
identifying milder cases on the spectrum (Fernandopulle, 2011).  Current tools to measure 
ASD should be validated (against clinical diagnoses) in order to ascertain their suitability at 
identifying a continuum of ASD symptoms.  New ASD measurement tools may be required 
moving forward.   
 
Consideration should also be given to the population sample being used.  Five of the studies 
included within the mean difference analysis utilised comparisons between general 
population and clinical samples (Ayaz et al., 2014; Grzadzinski et al., 2011; Kochhar et al., 
2011; Mulligan et al., 2009; Nijmeijer et al., 2009).  Sensitivity and specificity of the SCQ, in 
particular, has been found to differ between clinical (Allen, Silove, Williams & Hutchins, 2007) 
and community samples (Chandler et al., 2007) which may have contributed to the observed 
variability and impacted on the identified rates. 
 
Clinical and Research Implications 
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The high rates of comorbidity between the two disorders indicate the necessity to consider 
the presence of ASD symptomology when working clinically with children and adolescents 
with ADHD.  Future research attempting to better understand the underlying pathophysiology 
of ADHD or ASD should remain mindful of the high rates of co-occurring symptoms.  
 
Specifically, when working with children and adolescents with ADHD, psychological 
interventions should consider restrictive thinking styles commonly associated with ASD such 
as detailed-focus processing style (Happé & Frith, 2006) and a limited Theory of Mind (Happé 
& Frith, 1995).  Furthermore, therapeutic interventions that require children with ADHD to 
generalise learnt strategies or skills within multiple contexts may be particularly difficult for 
children who also experience symptoms of ASD (Rogers, 2000).  Further research into the 
efficacy of pharmacological and psychosocial interventions for ADHD should be reviewed in 
order to accommodate for the potential presence of ASD symptomology.   
 
As more research papers utilising the DSM-5 criteria for both ADHD and ASD are published, a 
further meta-analysis should be repeated to determine whether rates of ASD in young people 
with ADHD are comparable with rates identified in the current paper. 
 
Treatment Implications 
Due to high comorbidity between the two disorders it would be appropriate for specialist 
services to expand their service provision to accommodate for these two comorbid 
conditions.  These findings lend support for a move away from specialist ADHD and ASD 
services to wider neurodevelopmental specialist services that can address the common co-
occurring difficulties identified within children and adolescents with ADHD.  Future research 
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could expand on the findings of the current study and the potential benefits of developing 
neurodevelopmental specialist services.   
 
Currently, for young people there are recommended pharmacological treatments for severe 
ADHD (NICE, 2018), but there are no recommended medications that tackle the core features 
of ASD.   As the co-occurrence of ADHD and ASD results in greater functional impairments 
than each condition individually (Guttmann-Steinmetz, Gadow & DeVincent, 2009; Gadow, 
DeVincent & Schneider, 2009; Jang et al., 2013), treatment is then reliant on effective psycho-
social interventions for young people with both conditions.  Unfortunately, there is limited 
evidence as to the effectiveness of psycho-social interventions for young people with both 
ADHD and ASD (Murray, 2010).  Future non-pharmacological interventions should be adapted 




This is the first meta-analysis to investigate the rates of ASD in young people with ADHD.  
Findings from the current study further our understanding of the relationship between ADHD 
and ASD.  Acknowledging and addressing the presence of ASD symptomology when working 
with children and adolescents with ADHD will more accurately inform treatment 
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* A total of 22 studies were included within the two meta-analyses.  Craig et al., 2015, Green et al., 2015, Grzadzinski et al., 2011, 
Kochhar et al., 2010, Reiersen et al., 2007 & Salley et al., 2015 were included within both meta-analyses. 
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Figure 2. Forest Plot for the proportion of children and adolescents with ADHD that also met symptom threshold for ASD. 
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Figure 3. Forest Plot of mean difference of ASD symptoms between children and adolescents with and without ADHD. 
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Figure 4. Forest Plot of mean difference of ASD symptoms between clinical and community samples. 
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Table 1. Summary of studies included in proportion meta-analysis 
Study Country Total Sample 
Size 
Sample Source Diagnostic 
manual used 
Age of original 
sample in years 
ASD outcome measure* With ASD 
n/N (%) 
Craig et al., 2015 
 
Italy 181 Clinical DSM-IV 7-9 SCQ 13/51 (25.7) 
Green et al., 2015 
 
Australia 362 Community DISC-IV  6-10 SCQ 38/164 (33) 
Grzadzinski et al., 2016 
 
US 212 Clinical DSM-5  4-18  ADOS + ADI-R 7/48 (15) 
Grzadzinski et al., 2011 
 
US 144 Clinical DSM-IV TR 7-17 SRS 24/75 (32) 
Jensen et al., 2015 
 
Denmark 14,825 Community ICD-10 4-18 ICD-10 1,842/14,825 
(12.4) 
Kochhar et al., 2010 
 
UK 60 Clinical DSM-IV 9-15 SCQ 8/30 (28) 
Kotte et al., 2013 
 
US 469 Clinical DSM-III-R 6-18  CBCL 44/242 (18.2) 
Lichtenstein et al., 2010 
 
Sweden 17,036 Community DSM-IV 9-12 A-TAC 72/303 (23.7) 
Reiersen et al., 2007 
 
US 946 twins Community DSM-IV 7-19  Pooled SRS 29/134 (21.6) 
Ronald et al., 2008 
 
UK  6107 Community DSM-IV 7.88 (mean) DAWBA 31/137 (22) 
Russell et al., 2014 UK 14,043 Community Diagnosis 6-8 Health Professional 
confirmation 
42/173 (24.1) 
Salley et al., 2015 
 
US 209 Clinical DSM-5 3-18 ADOS 12/31 (40) 
Zablotsky et al., 2017 US 2464 Community DSMIV 4-17 Health Professional 
confirmation  
352/2464 (14) 
* ADI-R= Autism Diagnostic Interview-Revised; ADOS-2 = Autism Diagnostic Observation Schedule- Version 2; A-TAC = ASD-Tics, ADHD and other Comorbidities Inventory; DAWBA = 
Development and Well-being assessment; SCQ = Social Communication Questionnaire; SRS = Social Responsiveness Scale. 
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Table 2. Summary of studies included in mean difference meta-analysis. 
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*SRS = Social Responsiveness Scale, SCQ = Social Communication Questionnaire, ASSQ =  Autism Spectrum Screening Questionnaire, ABC = ASD Behavior Checklist, CASD = Checklist for 
ASD Spectrum Disorder,  CSBQ =  The Children’s Social Behavior Questionnaire,  ADOS = Autism Diagnostic Observation Schedule. 
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Table 3. Random effect meta-analyses of ASD symptoms in children and adolescents with ADHD. 
    Heterogeneity 
Analysis N of 
studies 




χ2 p I2 (%) 
Proportion analysis       
All Studies 13 0.21 0.18-0.24 94.10 <0.001 87.25 
Sample       
Clinical  6 0.24 0.17-0.31 12.14 <0.05 58.81 
Community 7 0.19 0.16-0.22 61.86 <0.001 90.30 
Measurement Tool       
Screening 9 0.22 0.18-0.26 40.20 <0.001 80.01 
Diagnostic 4 0.20 0.11-0.29 22.25 <0.001 86.52 
Country of Origin       
USA 6 0.21 0.15-0.26 23.37 <0.001 78.61 
Non-USA 7 0.22 0.16-0.28 59.15 <0.001 89.86 
       
 N of 
studies 




χ2 p I2 
Mean Difference analysis        
All Studies 15 1.23 0.94-1.51 210.69 <0.001 93.4 
Sample        
Clinical 10 1.45 1.04-1.86 141.86 <0.001 93.7 
Community 5 0.83 0.57-1.10 24.84 <0.001 83.9 
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